MedPath
HSA Approval

KANAMYCIN SULFATE INJECTION 1 g/3 ml

SIN01963P

KANAMYCIN SULFATE INJECTION 1 g/3 ml

KANAMYCIN SULFATE INJECTION 1 g/3 ml

June 23, 1988

PHARMAZEN MEDICALS PTE LTD

PHARMAZEN MEDICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAZEN MEDICALS PTE LTD
Licence HolderPHARMAZEN MEDICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAMUSCULAR

Medical Information

J01GB04

kanamycin

Manufacturer Information

PHARMAZEN MEDICALS PTE LTD

THAI MEIJI PHARMACEUTICAL CO LTD

Active Ingredients

KANAMYCIN SULPHATE EQV KANAMYCIN

1 g/3 ml

Kanamycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KANAMYCIN SULFATE INJECTION 1 g/3 ml - HSA Approval | MedPath